NxStage Medical, Inc. Reports Record First Quarter 2014 Financial Results And Exceeds Guidance

LAWRENCE, Mass., May 8, 2014 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today reported record first quarter financial results that exceed the top end of its guidance range.

Revenue for the first quarter of 2014 increased 17 percent to a record $72.2 million, compared with revenue of $61.6 million for the first quarter of 2013. The Company's revenue guidance range for the first quarter was $69.5 to $70.5 million. The increase in revenue was driven by continued strong adoption of the NxStage(R) System One(TM) hemodialysis machine within the Home, both within US and international markets, and the Critical Care market.

Help employers find you! Check out all the jobs and post your resume.